Pharmacokinetic evaluation and in vivo anti-inflammatory potential of cyanoacetate derivatives of succinimide
Open Access
- 22 July 2026
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (13) , 21411-21426
Abstract
The purpose of the study is to evalute the in vivo anti -inflammatory activity of newly synthesized cyanoacetate derivatives of succinimides (C-23, C-31, and C-44) and to elucidate their possible mechanisms of action through key inflammatory mediator pathways. Anti-inflammatory activity was assessed using carrageenan-induced paw oedema and arachidonic acid-induced ear oedema models in vivo. Mechanistic involvement was investigated through histamine-, prostaglandin-, leukotriene-, and bradykinin-induced paw oedema assays. In silico ADME studies were performed to predict pharmacokinetic properties and metabolic interactions. All tested compounds exhibited significant anti-inflammatory activity, with C-44 showing the highest potency. Mechanistic studies indicated that the anti-inflammatory effects were predominantly mediated via inhibition of prostaglandin and leukotriene pathways. ADME predictions suggested high gastrointestinal absorption, favourable oral bioavailability, and minimal interaction with major metabolic enzymes. The synthesized cyanoacetate derivatives, particularly C-44, demonstrate promising anti-inflammatory potential with favourable pharmacokinetic profiles, supporting their candidacy for further development as effective anti-inflammatory agents.Keywords
Funding Information
- Università degli Studi di Milano
This publication has 42 references indexed in Scilit:
- Physicochemical properties, drug likeness, ADMET, DFT studies, and in vitro antioxidant activity of oxindole derivativesComputational Biology and Chemistry, 2023
- The associations between endocrine disrupting chemicals and markers of inflammation and immune responses: A systematic review and meta-analysisEcotoxicology and Environmental Safety, 2022
- Catalytic Access to Succinimide Products Containing Stereogenic Quaternary CarbonsChemistrySelect, 2020
- Design, synthesis, in-vitro, in-vivo and in-silico studies of pyrrolidine-2,5-dione derivatives as multitarget anti-inflammatory agentsEuropean Journal of Medicinal Chemistry, 2020
- Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelinesJournal of Crohn's and Colitis, 2013
- The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosisExperimental Neurology, 2010
- Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected DiseasesChemMedChem, 2008
- Lead- and drug-like compounds: the rule-of-five revolutionDrug Discovery Today: Technologies, 2004
- The mast cell and mast cell diseaseJournal of the American Academy of Dermatology, 1995
- A new approach to practical acute toxicity testingArchives of Toxicology, 1983